The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think with DHA the clinical trials data are still not clear there's a pretty interesting setback on a clinical trial in the fall that was looking at a combination of EPA DHA and it was a trial that was stopped for futilities so there was no harm from it but there wasn't the big bang benefit that we frankly expected to see based on the earlier trial with the SEPA which was just EPA
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.